Efavirenz (EFV), the most popular non-nucleoside reverse transcriptase inhibitor, has been 21 associated with mitochondrial dysfunction in most in vitro studies. However, in real life the 22 prevalence of EFV-induced mitochondrial toxicity is relatively low. We hypothesized that the 23 agents given in combination with EFV might moderate the effect of EFV on mitochondrial 24 function. To test this hypothesis, we cultured human T lymphoblastoid cell line (CEM cells) with 25 EFV alone and in combination with emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) 26 to investigate the effects on mitochondrial respiration and function and cholesterol biosynthesis. 27 There was a statistically significant concentration-and time-dependent apoptosis, reduction in 28 mitochondrial membrane potential (ΔΨ), and increase production of reactive oxygen species 29 (ROS) in cells treated with either EVF alone or in combination with TDF/FTC. EFV treated 30 cells compared to DMSO treated cells had significant reduction in oxygen consumption rate 31 (OCR) contributed by mitochondrial respiration, ATP production-linked respiration, and spare 32 respiratory capacity (SRC). Treatment with EFV resulted in a decrease in mitochondrial DNA 33 content, and perturbation of more coding genes (n=13); among these were 11 genes associated 34 with lipid or cholesterol biosynthesis. Our findings support the growing body of knowledge on 35 the effects of EFV on mitochondrial respiration and function and cholesterol biosynthesis.
for ATP production, however, this percentage dropped to 50% with EFV treatment at the two 140 concentrations ( Figure 3C ). TDF/FTC treatment did not have an effect on the percentage of basal 141 respiration used to ATP production. Only treatment with 2xC max TDF/FTC and 2xC max 142 TDF/FTC/EFV had significant decrease in the percentage of MRC used for basal respiration 143 (p<0.05). Treatment with 1xC max EFV and 2xC max TDF/FTC/EFV caused a significant increase 144 in proportion of proton leak contributing to basal respiration. All treatments tended to reduce the 145 relative contribution of SRC to basal respiration, however, only treatment with 1xCmax 146 TDF/FTC, 2xC max TDF/FTC, and 2xC max TDF/FTC/EFV led to statistically significant reduction 147 (p<0.05). Treatment with 1xC max and 2xC max EFV increased the contribution of non-148 mitochondrial respiration to basal respiration. The RCR is a sensitive indicator of mitochondrial 149 dysfunction that is influenced by all components of ETC (18). RCR was computed as the ratio 150 between the maximal respiration and the respiration rate detected in the presence of oligomycin 151 (i.e., ATP production-linked respiration). All the treatment conditions tended to decrease RCR 152 compared to DMSO treatment, however, only treatment with 2xC max of TDF/FTC/EFV resulted 153 in a statistically significant decrease in RCR ( Figure 3D ).
154
Gene expression profiles of CEM cells treated with EFV, TDF, FTC, and TDF/FTC 155 We investigated the differential gene expression profiles of CEM cell treated with EFV (1x C max ), 156 TDF (4xC max ), FTC (4xC max ), and TDF/FTC (4xC max ) using Affymetrix GeneChip Human Gene 157 2.0 ST arrays. We used 4xC max of TDF and FTC because at lower concentrations, there was no 158 significant differential gene expression. The number of genes expressed with at least 2-fold 159 difference over cells treated with DMSO are illustrated in Figure 4A . There were no genes 160 expressed at the 2-fold threshold with FTC treated cells. Total number of coding genes perturbed 161 by TDF/FTC treatment was 3. EVF treatment led to perturbation of more coding genes (n=13); 162 among these were 11 genes associated with lipid or cholesterol biosynthesis. Figures 4B and 4C 163 illustrate the genes that were either down-or up-regulated by EFV and TDF/FTC treatment, 164 respectively.
165
EFV treatment was associated with down-regulation of genes associated with cholesterol 166 biosynthesis 167 With the finding of downregulation of genes of cholesterol biosynthesis by EFV and previously 168 reported effect of EFV on the lipogenic transcription factor sterol regulatory element binding 169 protient-1c (SREBP-1c) (24), we sought to validate our microarray data with quantitative PCR 170 ( Figure 5 ). Relative gene expression in cells treated with antiretroviral drugs was compared to 171 gene expression in cells treated with DMSO. Cells treated with EFV had a significant reduction 172 in 3-hydroxy-3-methylglutaryl-CoA synthases, HMGCS, (p<0.01) and 3-hydroxy-3-173 methylglutaryl-CoA reductase, HMGCR, (p<0.05) expressions ( Figure 5A ). Combination 174 treatment with TDF/FTV/EFV also decreased the expressions of HMGCS (p<0.01) and HMGCR 175 (p<0.05). TDF/FTC treatment did not have any significant effect on the expressions of HMGCS 176 and HMGCR. All treatment conditions had significant effect on insulin induced gene-1(INSIG-1) 177 but not insulin induced gene-2 (INSIG-2) ( Figure 5B ). EFV treatment resulted in significant Figure 5E ).
183

DISCUSSION
184
In this study, we sought to investigate whether combining EFV with TDF/FTC will 185 moderate reported EFV-associated mitochondrial dysfunction (8, 18, (25) (26) (27) and perturbation of 186 cholesterol biosynthesis (8, 28, 29) . Most of the reported EFV-induced toxicities are from in 187 vitro studies where cells were treated with EFV alone. However, in real life, EFV is used in The threshold at which mitochondrial dysfunction will translate into toxic phenotype in a 203 cell is not well understood; it depends on the type and energy requirement of the cell (30). In 204 CEM cells treated with EFV, we observed a reduction in mitochondrial respiration, ATP 205 production-linked respiration, and SRC ( Figure 3B ). These findings are consistent with effect of 206 EFV on mitochondrial respiratory parameters in human glioma, neuroblastoma, and HepG2 cell 207 lines (18, 31) and primary cultures of rat neurons and astrocytes (25) reported in previous studies.
208
In these studies, EVF was cultured with the cells for 1 h to 24 h, while we extended treatment for 209 48 hrs. The SRC of a cell translates into the ability of the cell to survive and function under high 210 energy demanding conditions (18). Decrease in SRC has been associated with heart diseases, 211 neurodegenerative disorders and aging (32). Interestingly, the prevalence of these conditions is 212 on the rise in HIV treatment-experienced individuals (33, 34) . We also observed an increase in 
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Our study, like all in vitro studies, has several limitations. First, we could not possibly 280 mimic or take into account all the complex biological pathways and processes that occur in vivo. 281 Second, the experiments were conducted using a cancer cell line whose cellular bioenergetics 282 may not be fully comparable to that of primary cells (18). We chose CEM cells because they can 283 be infected with HIV. Therefore, they can be used to tease out the relative contributions of HIV 284 infection and ART in mitochondrial dysfunction and cholesterol biosynthesis in future studies.
285
Third, one might argue that 2 days of culture may not be adequate to tease out the delayed effect 286 of EFV on mitochondria in real life. However, our duration is consistent with the duration used 287 in several in vitro studies of ART toxicity (51, 52) and the decrease in viability of CEM cells 288 with EFV treatment did not allow us to go beyond 48 h of culture.
289
In conclusion, EFV treatment resulted in reduction in mitochondrial respiratory 
305
Cell culture and cell viability 306 Human T lymphoblastoid cell line (CEM cells) was cultured in RPMI 1640 supplemented with 307 10% dialyzed fetal calf serum (Thermo Fisher Scientific, NY, USA). Cells were incubated at 308 37ºC in a 5% CO 2 humidified environment. 3 x 10 4 /ml cells (total volume of 40 ml) were 309 incubated with EFV, FTC, or TDF at multiples of plasma peak concentration, e.g., 1xC max , or 310 2xC max . The cells were collected for cell count and the experiments described below each day. an-xf-assay) and as previously published (18, 35) . In brief, the Agilent Seahorse uses modulators 362 of respiration that target components of the electron transport chain. The compounds 363 (oligomycin, FCCP, and a mix of rotenone and antimycin A) were serially injected to measure 364 ATP production, maximal respiration, and non-mitochondrial respiration, respectively. Proton 365 leak and spare respiration capacity (SRC) were then calculated using these parameters and basal 366 respiration. Treated CEM cells were seeded at a density of 1.2 x 10 5 cells per well in triplicate in 367 a 1% gelatin treated 96 -well plate. Then, the sensor cartridge was load with oligomycin, FCCP, 368 and a mixture of rotenone and antimycin A in ports A, B, and C, respectively. The cell culture 369 plate was then inserted into the analyzer and programed to ensure a homogenous environment.
370
For each phase, measurements were performed in triplicate, totaling 12 points per trace. To allow 371 for comparison between different experiments, the data obtained for each condition were 372 normalized to the cell number per well and expressed as the oxygen consumption rate (OCR) in 373 pmol/min. The experiment was repeated three times. No significant inter-assay differences were 374 detected between the three repeats with regard to appearance and viability of cell or the values of 375 OCR that were obtained. 
